Drugs belonging to class 'Tyrosine kinase inhibitor'

See adverse reactions attributed to class 'Tyrosine kinase inhibitor'

Drug NameCompare
Afatinibcompare
Asciminibcompare
Avapritinibcompare
Axitinibcompare
Bosutinibcompare
Brigatinibcompare
Cabozantinibcompare
Crizotinibcompare
Dacomitinibcompare
Dasatinibcompare
Erdafitinibcompare
Erlotinibcompare
Gefitinibcompare
Imatinibcompare
Lapatinibcompare
Leflunomidecompare
Lenvatinibcompare
Mobocertinibcompare
Neratinibcompare
Nilotinibcompare
Nintedanibcompare
Osimertinibcompare
Pazopanibcompare
Ponatinibcompare
Pralsetinibcompare
Regorafenibcompare
Ripretinibcompare
Sorafenibcompare
Sunitinibcompare
Tivozanibcompare
Trastuzumabcompare
Tucatinibcompare
Vandetanibcompare
Zanubrutinibcompare

 

Adverse reactions attributed to entire drug class 'Tyrosine kinase inhibitor'

Please login to view adverse reactions

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top